The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation
02 nov. 2017 18h54 HE
|
The Canadian Bioceutical Corporation
Election of Board of DirectorsAppoint Deloitte LLP as AuditorAppointment of OfficersIssuance of Stock OptionsEntering into Executive Services Agreement with Canadian Capital, LLC TORONTO, Nov. 02,...
BCC Provides Update on Health Canada Licensed Producer Application and Owen Sound Facility Build Out
26 oct. 2017 07h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced it has completed preparatory construction work and...
BCC Announces Initial US$10 Million Drawdown on Credit Facility
24 oct. 2017 18h20 HE
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 24, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that it made an initial drawdown of US$10 million under...
BCC Announces Annual Meeting Details
13 oct. 2017 10h30 HE
|
The Canadian Bioceutical Corporation
Refresh Board of Directors Appoint Deloitte LLP as Auditors Name Change to MPX Bioceutical Corporation TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the...
BCC Signs Definitive Agreement to Expand Into Second Adult Use Market
13 oct. 2017 07h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today announced that, the Company, through its wholly-owned U.S....
BCC Reports Q1 Fiscal 2018 Results
28 sept. 2017 21h35 HE
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) reported its financial results for the first quarter of fiscal 2018,...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
21 sept. 2017 11h08 HE
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 21, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...
BCC Reports Q4 and Fiscal 2017 Results
08 sept. 2017 07h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 08, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) today reported its financial results for the fourth quarter and full...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
07 sept. 2017 23h00 HE
|
The Canadian Bioceutical Corporation
TORONTO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...
BCC Provides Bi-Weekly Update on Status of Management Cease Trade Order
23 août 2017 23h20 HE
|
The Canadian Bioceutical Corporation
TORONTO, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company” or “BCC”) (CSE:BCC) (OTC:CBICF) further to missing the July 31, 2017 deadline for filing its audited...